Strategic Biotech Support The NemetzGroup provides hands-on strategic support to biopharma teams, presenting a potential upsell to larger biopharma firms seeking external expertise for commercialization planning and execution.

Leadership Momentum Promotion of Marnie Hoolahan to president signals leadership depth and new strategic direction, which can be a catalyst for engagement with clients undergoing leadership transitions or organizational changes.

Mid-market Focus With a 11-50 employee size and revenue in the 1M-10M range, The NemetzGroup sits in the mid-market segment—representing an opportunity to upsell scalable consulting services, project-based engagements, and retainer arrangements to growing biopharma teams.

Tech Enablement Utilizing a modern tech stack (Google Workspace, PWA, JSON-LD, Open Graph) suggests openness to digital collaboration and data-driven projects, enabling sales proposals that emphasize efficient remote consulting, data management, and scalable workflows.

Industry Positioning As a boutique advisory in biotech commercialization, there is potential to partner with larger CROs, pharma services firms, or similar consultancies seeking specialized biopharma commercialization expertise to augment capabilities or extend market reach.